Rhabdomyolysis and Metabolic Myopathy
Gene: SLC22A5
Well established gene-disease association, curated definitive by ClinGen Fatty Acid Oxidation Disorders Gene Curation Expert Panel (PMID: 31399326).Created: 8 May 2022, 11:25 p.m. | Last Modified: 8 May 2022, 11:25 p.m.
Panel Version: 0.13930
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Carnitine deficiency, systemic primary, MIM# 212140, MONDO:0008919
Publications
Well reported in patients with systemic primary carnitine deficiency. Severity and age of onset can be variably however usually manifests in infancy or early childhood. Skeletal and cardiac manifestations are common.Created: 15 Jun 2020, 6:21 a.m. | Last Modified: 15 Jun 2020, 6:21 a.m.
Panel Version: 0.176
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Carnitine deficiency, systemic primary (MIM#212140)
Publications
>3 cases and a mouse model. Protein has a function in carnitine-dependent oxidation of long-chain fatty acids in mitochondria and is essential for normal gut function.
Sources: NHS GMS, LiteratureCreated: 20 Mar 2020, 8:07 a.m.
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Carnitine deficiency, systemic primary MIM#212140
Publications
Gene: slc22a5 has been classified as Green List (High Evidence).
Publications for gene: SLC22A5 were set to
Tag treatable tag was added to gene: SLC22A5.
gene: SLC22A5 was added gene: SLC22A5 was added to Rhabdomyolysis_RMH. Sources: Royal Melbourne Hospital,Expert Review Green Mode of inheritance for gene: SLC22A5 was set to BIALLELIC, autosomal or pseudoautosomal Phenotypes for gene: SLC22A5 were set to Carnitine deficiency, systemic primary 212140